1912 related articles for article (PubMed ID: 28748386)
1. Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis.
McClung MR; Lippuner K; Brandi ML; Zanchetta JR; Bone HG; Chapurlat R; Hans D; Wang A; Zapalowski C; Libanati C
Osteoporos Int; 2017 Oct; 28(10):2967-2973. PubMed ID: 28748386
[TBL] [Abstract][Full Text] [Related]
2. Updated trabecular bone score accounting for the soft tissue thickness (TBS
Hans D; Shevroja E; McDermott M; Huang S; Kim M; McClung M
Osteoporos Int; 2022 Dec; 33(12):2517-2525. PubMed ID: 36115888
[TBL] [Abstract][Full Text] [Related]
3. Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial.
Bilezikian JP; Hattersley G; Fitzpatrick LA; Harris AG; Shevroja E; Banks K; Leder BZ; Zanchetta JR; Hans D
Osteoporos Int; 2018 Feb; 29(2):323-328. PubMed ID: 29167971
[TBL] [Abstract][Full Text] [Related]
4. Long-term effect of denosumab on bone microarchitecture as assessed by tissue thickness-adjusted trabecular bone score in postmenopausal women with osteoporosis: results from FREEDOM and its open-label extension.
Hans D; McDermott M; Huang S; Kim M; Shevroja E; McClung M
Osteoporos Int; 2023 Jun; 34(6):1075-1084. PubMed ID: 36862192
[TBL] [Abstract][Full Text] [Related]
5. Effects of Teriparatide, Denosumab, or Both on Spine Trabecular Microarchitecture in DATA-Switch: a Randomized Controlled Trial.
Tsai JN; Jiang LA; Lee H; Hans D; Leder BZ
J Clin Densitom; 2017; 20(4):507-512. PubMed ID: 28624340
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study.
Senn C; Günther B; Popp AW; Perrelet R; Hans D; Lippuner K
Osteoporos Int; 2014 Jul; 25(7):1945-51. PubMed ID: 24760244
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal changes in bone mineral density and trabecular bone score following yearly zoledronic acid infusion in postmenopausal osteoporosis-a retrospective-prospective study from southern India.
Sooragonda B; Cherian KE; Jebasingh FK; Dasgupta R; Asha HS; Kapoor N; Thomas N; Paul TV
Arch Osteoporos; 2019 Jul; 14(1):79. PubMed ID: 31321603
[TBL] [Abstract][Full Text] [Related]
8. The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study.
Papapoulos S; Lippuner K; Roux C; Lin CJ; Kendler DL; Lewiecki EM; Brandi ML; Czerwiński E; Franek E; Lakatos P; Mautalen C; Minisola S; Reginster JY; Jensen S; Daizadeh NS; Wang A; Gavin M; Libanati C; Wagman RB; Bone HG
Osteoporos Int; 2015 Dec; 26(12):2773-83. PubMed ID: 26202488
[TBL] [Abstract][Full Text] [Related]
9. Effects of Teriparatide and Sequential Minodronate on Lumbar Spine Bone Mineral Density and Microarchitecture in Osteoporosis.
Miyaoka D; Imanishi Y; Ohara M; Hayashi N; Nagata Y; Yamada S; Mori K; Emoto M; Inaba M
Calcif Tissue Int; 2017 Oct; 101(4):396-403. PubMed ID: 28589205
[TBL] [Abstract][Full Text] [Related]
10. Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.
Leslie WD; Martineau P; Bryanton M; Lix LM
Osteoporos Int; 2019 Jul; 30(7):1445-1453. PubMed ID: 31016351
[TBL] [Abstract][Full Text] [Related]
11. The lumbar spine age-related degenerative disease influences the BMD not the TBS: the Osteolaus cohort.
Padlina I; Gonzalez-Rodriguez E; Hans D; Metzger M; Stoll D; Aubry-Rozier B; Lamy O
Osteoporos Int; 2017 Mar; 28(3):909-915. PubMed ID: 27900426
[TBL] [Abstract][Full Text] [Related]
12. Change in Trabecular Bone Score (TBS) With Antiresorptive Therapy Does Not Predict Fracture in Women: The Manitoba BMD Cohort.
Leslie WD; Majumdar SR; Morin SN; Hans D; Lix LM
J Bone Miner Res; 2017 Mar; 32(3):618-623. PubMed ID: 27933656
[TBL] [Abstract][Full Text] [Related]
13. Effects of anti-resorptive agents on trabecular bone score (TBS) in older women.
Krieg MA; Aubry-Rozier B; Hans D; Leslie WD;
Osteoporos Int; 2013 Mar; 24(3):1073-8. PubMed ID: 23052939
[TBL] [Abstract][Full Text] [Related]
14. Comparisons of TBS and lumbar spine BMD in the associations with vertebral fractures according to the T-scores: A cross-sectional observation.
Lee JE; Kim KM; Kim LK; Kim KY; Oh TJ; Moon JH; Choi SH; Lim S; Kim SW; Shin CS; Jang HC
Bone; 2017 Dec; 105():269-275. PubMed ID: 28963079
[TBL] [Abstract][Full Text] [Related]
15. Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT).
Sugimoto T; Matsumoto T; Hosoi T; Miki T; Gorai I; Yoshikawa H; Tanaka Y; Tanaka S; Fukunaga M; Sone T; Nakano T; Ito M; Matsui S; Yoneda T; Takami H; Watanabe K; Osakabe T; Okubo N; Shiraki M; Nakamura T
Osteoporos Int; 2015 Feb; 26(2):765-74. PubMed ID: 25403903
[TBL] [Abstract][Full Text] [Related]
16. Effect of denosumab on trabecular bone score in de novo kidney transplant recipients.
Bonani M; Frey D; Graf N; Wüthrich RP
Nephrol Dial Transplant; 2019 Oct; 34(10):1773-1780. PubMed ID: 30932161
[TBL] [Abstract][Full Text] [Related]
17. Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: a three-year study.
Popp AW; Guler S; Lamy O; Senn C; Buffat H; Perrelet R; Hans D; Lippuner K
J Bone Miner Res; 2013 Mar; 28(3):449-54. PubMed ID: 23018784
[TBL] [Abstract][Full Text] [Related]
18. Use of Trabecular Bone Score (TBS) as a Complementary Approach to Dual-energy X-ray Absorptiometry (DXA) for Fracture Risk Assessment in Clinical Practice.
Shevroja E; Lamy O; Kohlmeier L; Koromani F; Rivadeneira F; Hans D
J Clin Densitom; 2017; 20(3):334-345. PubMed ID: 28734710
[TBL] [Abstract][Full Text] [Related]
19. Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study.
Hans D; Goertzen AL; Krieg MA; Leslie WD
J Bone Miner Res; 2011 Nov; 26(11):2762-9. PubMed ID: 21887701
[TBL] [Abstract][Full Text] [Related]
20. Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group.
Bilezikian JP; Lin CJF; Brown JP; Wang AT; Yin X; Ebeling PR; Fahrleitner-Pammer A; Franek E; Gilchrist N; Miller PD; Simon JA; Valter I; Zerbini CAF; Libanati C; Chines A
Osteoporos Int; 2019 Sep; 30(9):1855-1864. PubMed ID: 31201481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
